Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2Osteosarcoma 1Neoplasm Metastasis 1Adenoma, Islet Cell 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Everolimus 3lutetium Lu 177 dotatate 2Temozolomide 2Sunitinib 2sargramostim 1montanide ISA 51 1lanreotide 1incomplete Freund's adjuvant 1fludarabine phosphate 1belzutifan 1Sorafenib 1Radiofrequency Ablation 1Octreotide 1Interleukin-13 1Histocompatibility Testing 1Gefitinib 1Fulvestrant 1Fluorodeoxyglucose F18 1Cytoreduction Surgical Procedures 1Cyclophosphamide 1Colony-Stimulating Factors 1Capecitabine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenoma, Islet Cell × Gefitinib × Clear all
NCT06592989 2025-01-10

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
20 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡